Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children

Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive"

NCT05715918 ·Status: UNKNOWN ·Phase: PHASE3

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years

NCT06614816 ·Status: COMPLETED ·Phase: PHASE3

Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate

NCT05226390 ·Status: TERMINATED ·Phase: PHASE1

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

NCT05084508 ·Status: COMPLETED ·Phase: PHASE2

Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age

NCT05506969 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

NCT01461993 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

NCT06810934 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)

NCT02180295 ·Status: WITHDRAWN ·Phase: PHASE3

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

NCT05013983 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

NCT00914732 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

NCT00849069 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

NCT04816669 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

NCT06740630 ·Status: RECRUITING ·Phase: PHASE3

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults

NCT04142086 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)

NCT02519855 ·Status: COMPLETED ·Phase: PHASE3

The HPV 9-10 Trial: Early Initiation of HPV Vaccination

NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age

NCT06693895 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

NCT00130793 ·Status: COMPLETED ·Phase: PHASE3

A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

NCT06998004 ·Status: COMPLETED ·Phase: PHASE1

NDV-HXP-S Vaccine Clinical Trial (COVIVAC)

NCT05940194 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

NCT00707967 ·Status: COMPLETED ·Phase: PHASE2

Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)

NCT00822237 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

NCT01160172 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers

NCT06975319 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

NCT02270944 ·Status: COMPLETED ·Phase: PHASE2